Dates: Wednesday, 26 August 2015

Medical Devices and Health Technology Assessment: Resolving the Puzzle  

Thursday, 27 August 2015 Compliance and Ethics: Central to your Business or on the Periphery?

  Time:

08h30 – 17h00 (Cocktails 17h30 – 19h30 on the 26th)

  Venue:

The Forum The Campus Office Park

Bryanston  

Cost: One day delegate - R2223 Two day delegate  - R3420

10% discount for 3 or more delegates per Company  

RSVP Date: RSVP by 12 August.

Please complete the attached electronic registration form

DRAFT PROGRAMME Wednesday 26 August 2015

Medical Devices and Health Technology Assessment: Resolving the Puzzle  

Various sectors / disciplines – national government, funders, professional associations, private and public hospitals, coding specialists – will share how they review Medical Device Technology.   An array of different technologies will be focused on ie Diagnostics, Point of care, Equipment and Implants etc. Also debated will be the value and potential for a single HTA entity for SA.   Key topics to be explored: •  NDoH Policy on HTA and Health Technology Management •  NHLS: Bringing New Technology to Market •  Point Of Care Testing: The new frontier, embrace rather than resist •  Health Economic Models for Reimbursement of Medical Devices

in Europe, what can we learn in South Africa? •  Assessing new capital equipment for procurement – what is the

process and what should suppliers submit? •  The outsourcing model used for the provision of services to

GEMS, and how the linkage between provider organisations is maintained

•  Viewpoint on Adoption, Use of and reimbursement challenges regarding New Technology in the Orthopaedic arena

•  Developing Treatment Protocols, Pitfalls and Successes •  Minimum Requirements for Coding and Tariff Development for

New Technology/Procedures •  A single entity for HTA in South Africa – possibility or pie in the

sky? •  What is needed to ensure a standardised approach to HTA in SA.  

Thursday 27 August 2015 Compliance and Ethics: Central to your business or on the periphery?

  Key persons from various sectors / disciplines – national government, industry, consultants, doctor societies, competition commission inquiry, international med tech associations etc, will share their views on the importance of ethics and compliance and emerging trends impacting the medical device industry in South Africa.   Key topics to be explored: •  Perspectives on anti-corruption, business ethics, innovation &

partnerships: making tangible efforts to ensure that business, government and the medical device industry work together to bring about necessary change.

•  Role of the Special Investigations Unit •  Outcomes of the Competition Commission inquiry into

Healthcare •  Ethical product usage in the Orthopaedic sector – role of the

South African National Joint Registry •  Direct sponsorship of Healthcare Professionals to third-party

organized conferences: global trends and challenges •  Industry is planning to move out of direct sponsorship across the

world and more particularly in Europe, China and Brazil. Could this happen in South Africa?

•  How do physicians and doctor societies view the changing compliance landscape and its effect on continuing medical education of healthcare professionals

•  Moving to new models of support for medical education •  Legal and business leaders will provide their thoughts on ethics

and compliance (e.g. transparency, direct sponsorship, contracting private nurses), what they have implemented and / or would like to see in terms of compliance in their company

•  Trends on FCPA and Sunshine Act and how these impact American healthcare companies doing business in South Africa.

•  Where is the compliance officer / manager profession headed? It’s place within the company, as well as the existing training programs and educational pathways for compliance practitioners

 

Invited speakers:   Sam Bakhane, Director Health Technology, National Department of Health Sarvashni Moodliar, Manager: National QA Operation & Support Academic Affair, Research & Quality Assurance, National Health Laboratory Service Professor Rajiv Erasmus, Professor and Head, Department of Chemical Pathology, Tygerberg Hospital University of Stellenbosch, President of South African Association of Clinical Biochemistry Dr Tamlyn Rautenberg, Independent Annelia Bezuidenhout, Procurement General Manager, Mediclinic South Africa Dr Guni Goolab, Principal Officer, GEMS Dr Allan van Zyl, Immediate Past President and Head, SA Orthopaedic Association Coding Committee Dr Chris Archer, CEO, the South African Private Practitioners Forum Casper Venter, Director, HealthMan Judith Horne, Chairperson, SAMED Health Economics and Reimbursement committee Shelley McGee, Health Economist, Priority Cost Effective Lessons for Systems Strengthening (PRICELESS) MRC |Wits Rural Public Health and Health Transitions Unit Debjani Mueller, Senior Researcher: CMeRC, Charlotte Maxeke Research Consortium University of the Witwatersrand, Secretary of the interim executive committee of Southern African Health Technology Assessment Society Professor Manie De Klerk, General Manager: Out of Hospital Programmes, Metropolitan Health Risk Management Dr Mamaqhawe Hoohlo, Senior Manager Clinical Unit, Council for Medical Schemes   CPD Point Allocation – 4 Ethics & 4 Clinical

Invited speakers:   Dr Anban Pillay, Deputy Director General, Health Regulation & Compliance Management, NDoH Advocate Gerhard Visagie, Acting Head, Special Investigations Unit Panel member of Competition Commission Inquiry into Healthcare - speaker to be confirmed KPMG Life Sciences Division - speaker to be confirmed Dr Jacques Botha, CEO of the South African National Joint Registry Dr Haseena Gani, Executive Officer, Marketing Code Authority Vanessa Moodley, Chairperson: Business Practices Committee (HPCSA) Dr Heidi K. Jauch, Vice President, Compliance Officer, for Zimmer covering Europe, the Middle East, and Africa Natalie Zimmelman, CEO, SA Society of Anaesthesiologist Dr Nikki Allorto, President, South African Burn Society Michael Judin, Goldman Judin Inc. Attorneys Adam Rappaport, Associate General Councel – Intl. Law, C.R. Bard Amanda Wilde, MD & Company Guardian, Umsinsi Health Care Albert Denoon, CEO, Baroque Medical Kevin Dand, CEO, Siemens Healthcare Dave Thomas, Vice President & General Manager Consumer Healthcare Southern Africa, GlaxoSmithKline Tanushiya Mudely, Commercial Assurance Manager Africa & Middle East, Becton Dickinson Alison Jeffries, Legal Advisor Regulatory, Baroque Medical Roeland Van Aelst, Regional Vice President - HCCO MD&D EMEA & Canada, Janssen Pharmaceutica CPD Point Allocation – 8 Ethics & 2 Clinical

Please note that Speakers are subject to change due to unforeseen circumstances.

������

!

Thank You to our Sponsors